HYPD — Hyperion DeFi, Inc.
NASDAQ · Healthcare · Biotechnology
$3.06
-$0.02 (-0.81%)
Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ. It is led by Hyunsu Jung, based in 3090 Nowitzki Way, Dallas, TX, United States, 75219, with about 9 employees. Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Latest reported HYPD revenue for 2025-09-30 was $302.5K. Net income was $6.6M. Revenue was up 1955.1% from 2025-06-30 to 2025-09-30. HYPD currently screens at market cap $48.5M.
Use this HYPD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HYPD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HYPD SEC filings page. Lician reads the product cache first so this HTML stays unique to Hyperion DeFi, Inc. even when a live quote feed is slow.
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
HYPD Key Statistics
Market Cap
$48.50M
Volume
784,878
Previous Close
$3.26
Day Range
$3.26 – $3.58
P/B Ratio
0.76
EPS
-$59.81
Revenue
$57.34K
Net Income
-$49.82M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+1414.0%
Profit Margin
-86888.6%
Employees
9
HYPD Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $57.34K | $3.79K | $0.00 | $14.00M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$49.82M | -$27.26M | -$28.01M | -$12.78M |
| EPS (Diluted) | -$59.81 | -$53.15 | -$0.83 | -$0.49 |
Total Assets
$3.67M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$2.12M
Operating Cash Flow
-$30.12M
Free Cash Flow
$0.00
Hyperion DeFi, Inc. Company Information
- CEO, Chief Investment Officer & Director
- Hyunsu Jung
- Headquarters
- 3090 Nowitzki Way, Dallas, TX, United States, 75219
- Website
- hyperiondefi.com
- Phone
- 833 393 6684
- IPO / Founded
- 2018-01-25
- Sector
- Healthcare
- Industry
- Biotechnology